Equities

Polyrizon Ltd

PLRZ:NAQ

Polyrizon Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.98
  • Today's Change-0.10 / -9.26%
  • Shares traded1.28k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 20:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..

  • Revenue in USD (TTM)0.00
  • Net income in USD-997.00k
  • Incorporated2005
  • Employees1.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Synaptogenix Inc0.00-3.45m3.71m5.00--0.1827-----3.89-3.890.0014.990.00----0.00-5.54-40.33-6.89-43.36------------0.00-------142.17---3.21--
Azitra Inc408.20k-9.96m3.74m10.00--0.2724--9.15-12.12-12.120.11511.800.0595--1.8340,820.00-145.30---194.72-------2,440.46------0.0191--141.55--6.02------
Hepion Pharmaceuticals Inc0.00-28.37m3.74m22.00--2.01-----6.49-6.490.000.61420.00----0.00-133.45-61.43-167.53-68.82------------0.00-------7.92------
Oragenics Inc7.47k-19.52m3.83m5.00------512.31-6.99-6.990.00230.23770.0013----1,494.00-349.31-97.60-451.26-106.24-----261,261.60-36,169.75----0.00---71.37---44.56--51.64--
Alaunos Therapeutics Inc7.00k-19.13m3.84m1.00--1.02--549.00-11.95-11.950.00442.360.0004--1.757,000.00-117.34-74.83-143.58-89.57-----273,271.40-10,508.06----0.00---99.83-49.086.86---15.56--
ProtoKinetix, Inc.0.00-369.97k3.84m0.00--9.12-----0.0011-0.00110.000.00120.00-------78.67-696.88-85.20-785.51------------0.00------78.22--10.78--
Therapeutic Solutions International Inc91.38k-2.00m3.91m3.00--2.84--42.76-0.0005-0.00050.000020.00030.02521.295.2430,460.00-63.67-162.32-153.29--65.1867.79-2,530.31-2,391.850.3883-6.940.3164---52.1395.3543.11------
Dogwood Therapeutics Inc0.00-5.30m3.96m4.00--1.05-----6.51-6.510.002.820.00----0.00-119.71-79.80-135.31-89.54------------0.00------56.76------
Correlate Energy Corp5.65m-34.51m4.01m19.00------0.7101-0.8359-0.83590.1457-0.04611.50--11.12297,377.40-915.61-315.47-----6.4515.42-610.79-201.03---1.33----122.2046.12-78.54------
Polyrizon Ltd0.00-997.00k4.11m1.00---------0.2377-0.23770.000.0529------0.00-------------------1.930.4048------22.98------
Genprex Inc0.00-26.14m4.14m26.00--0.941-----16.04-16.040.001.700.00----0.00-232.21-92.06-318.88-98.32------------0.00-------29.99---7.13--
Weed Inc0.0057.30k4.31m2.0068.42573.0049.83--0.00050.00050.000.000060.00----0.006.00-385.93---822.37-----------46.080.944------97.93---59.13--
Portage Biotech Inc0.00-71.08m4.43m7.00--1.76-----68.81-68.810.002.390.00----0.00-137.29-30.53-143.21-40.02------------0.02------27.98------
Aptevo Therapeutics Inc0.00-25.25m4.49m40.00--0.222-----46.21-45.630.001.090.00----0.00-115.20-47.16-160.28-85.03-------583.47----0.00---100.00---365.90------
Galmed Pharmaceuticals Ltd0.00-5.88m4.51m3.00--0.1344-----24.68-24.680.0022.250.00----0.00-44.20-45.06-52.67-50.79------------0.00------61.31------
Data as of Nov 13 2024. Currency figures normalised to Polyrizon Ltd's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.